One-Pager

GI Bleeding, Liver Failure and Pancreatitis

Upper GI and variceal bleeding, encephalopathy, SBP, acute liver failure and pancreatitis

Reviewed by Alex G, BSN, RN, CEN, CCRN, CMC, NREMT-P · Checked against current sources October 2026

Download one-page PDFLetter landscape, ready to print or keep with your notes

Upper GI bleeding

Variceal bleed (cirrhosis)Do
Vasoactive drugOctreotide as soon as suspected, 2–5 days
AntibioticCeftriaxone 1 g/day, up to 7 days
EndoscopyWithin 12 h: band ligation
High risk (Child C, or B with active bleeding)Pre-emptive TIPS within 72 h
UncontrolledBalloon tamponade as a bridge; intubate first

Cirrhosis and liver failure

ProblemCluesTreatment
Hepatic encephalopathyConfusion, asterixis; find the triggerLactulose to 2–3 soft stools a day; add rifaximin
Spontaneous bacterial peritonitisAscitic neutrophils 250/mm³ or moreCeftriaxone or cefotaxime plus albumin (day 1 and 3)
Large paracentesisOver 5 L removedAlbumin 6–8 g per liter removed
Hepatorenal syndromeRising creatinine despite albuminAlbumin plus terlipressin or norepinephrine

Encephalopathy triggers: GI bleeding, infection, low K, constipation, sedatives, dehydration.

Acute liver failure: INR 1.5 or more plus encephalopathy in a patient without cirrhosis. Acetaminophen is the top US cause: give acetylcysteine (also helps other causes). Call a transplant center early; check glucose often; ammonia over 150–200 raises cerebral edema risk (HOB 30°, sodium 145–155).

Acute pancreatitis

Practice GI Bleeding, Liver Failure and Pancreatitis questions free in your browser55 exam-style questions with rationales. No account or download needed.

In depth

The one-page summary above is what the PDF prints. These sections go further.

Upper GI bleeding: risk scores and resuscitation

Peptic ulcer is the leading upper GI source, then varices, erosive disease, Mallory-Weiss tears and angioectasia. As little as 50–100 mL of blood can cause melena, and digested blood raises the BUN; a BUN/creatinine ratio above 30 favors an upper source (Srygley 2012).

ScoreComponentsPredicts
Glasgow-Blatchford (0–23)BUN, Hgb, SBP, HR, melena, syncope, liver or heart failureNeed for intervention; 0–1: outpatient (ACG 2021)
AIMS65 (0–5)Albumin <3.0, INR >1.5, mentation, SBP ≤90, age ≥65Death: 0.3% at 0, 31.8% at 5 (Saltzman 2011)
Full Rockall (0–11)Age, shock, comorbidity, diagnosis, stigmataRebleeding and death; ≤2 is low risk

Transfuse at 7 g/dL, about 8 with cardiovascular disease (ACG 2021). Villanueva 2013 (921 patients, 7 vs 9 g/dL) found better 6-week survival (95% vs 91%) and less rebleeding (10% vs 16%) with restriction; the survival gain was in Child-Pugh A and B cirrhosis, and portal pressure rose only in the liberal arm.

Erythromycin 250 mg IV 30–120 min before endoscopy clears the stomach (check the QTc). Pre-endoscopic PPI downstages stigmata without changing outcomes; ACG 2021 made no recommendation either way. Endoscopy within 24 h is the target; sooner did not help in Lau 2020 (516 patients, Glasgow-Blatchford ≥12: 30-day mortality 8.9% within 6 h vs 6.6% at 6–24 h). Tranexamic acid failed in HALT-IT (2020, 12,009 patients): death from bleeding 4% in both arms, venous thromboembolism 0.8% vs 0.4%.

Endoscopic stigmata, rebleeding and lower GI bleeding

Rebleeding without endoscopic therapy, Laine and Peterson 1994.
ForrestUlcer baseRebleedingEndoscopic therapy
Ia, IbSpurting or oozing55%Yes
IIaNonbleeding visible vessel43%Yes
IIbAdherent clot22%Consider after clot removal
IIcFlat pigmented spot10%No
IIIClean base5%No; early feeding and discharge

Bipolar or heater-probe coagulation, clips and absolute ethanol work; epinephrine injection needs a second method. After hemostasis, give high-dose PPI for 3 days (80 mg IV, then 8 mg/h or intermittent boluses), then oral PPI twice daily to day 14. Rebleeding gets repeat endoscopy (over-the-scope clips), then transcatheter embolization (ACG 2021), with surgery last. Retest a negative H. pylori result, because acute bleeding causes false negatives.

Lower GI bleeding is most often diverticular and usually stops on its own. In hematochezia with shock, exclude an upper source first (about 10–15%, ACG 2016); a shock index (HR/SBP) above 1 marks instability (BSG 2019). An Oakland score of 8 or less predicts a 95% chance of safe discharge (Oakland 2017). For ongoing hemodynamically significant bleeding, ACG 2023 suggests CT angiography first and embolization if it is positive; other inpatients get a nonurgent colonoscopy after bowel preparation, because colonoscopy within 24 h has not reduced rebleeding or death.

Portal hypertension and acute variceal bleeding

Portal pressure gradient = flow × resistance. Fibrosis fixes most intrahepatic resistance; stellate-cell contraction (low nitric oxide, high endothelin) adds a dynamic part. Splanchnic vasodilation raises inflow and creates a hyperdynamic, sodium-retaining circulation. Variceal wall tension rises with pressure and diameter (Laplace), so large varices with red wale marks rupture, and overfilling raises portal pressure.

The hepatic venous pressure gradient (HVPG), wedged minus free hepatic venous pressure, reflects sinusoidal pressure and misses presinusoidal disease such as portal vein thrombosis.

Baveno VII; 12 mm Hg from Garcia-Tsao 1985. HVPG ≥20 early in a bleed: 1-year mortality 64% vs 20% (Moitinho 1999).
HVPG (mm Hg)Meaning
1–5Normal
≥10Clinically significant portal hypertension (CSPH)
≥12Varices can bleed
>20 during a bleedTreatment failure likely: pre-emptive TIPS

Nonselective beta-blockers cut cardiac output (β₁) and splanchnic inflow (unopposed α after β₂ blockade); carvedilol's α₁ blockade also lowers intrahepatic resistance. Baveno VII prefers carvedilol for CSPH after PREDESCI (decompensation or death 16% vs 27%) and reduces or stops beta-blockers with ascites if SBP falls below 90, MAP below 65, or HRS-AKI develops.

Class A 5–6, B 7–9, C 10–15 points.
Child-Pugh1 point2 points3 points
Bilirubin (mg/dL)<22–3>3
Albumin (g/dL)>3.52.8–3.5<2.8
INR<1.71.7–2.3>2.3
AscitesNoneMild or controlledModerate to severe
EncephalopathyNoneGrade 1–2Grade 3–4
StepBaveno VII (2022)
TransfusionTarget Hgb 7–8 g/dL
Vasoactive drugOn suspicion, before endoscopy; continue 2–5 days
AntibioticFrom admission; ceftriaxone 1 g every 24 h
AirwayIntubate if obtunded or vomiting blood
CoagulationNo FFP for the INR; no factor VIIa or tranexamic acid
EndoscopyWithin 12 h; ligation, or glue for fundal varices
EncephalopathyLactulose to clear blood from the gut
PPIStop after endoscopy unless otherwise indicated

Octreotide, the US agent, is 50 mcg IV, then 50 mcg/h; terlipressin is 2 mg IV every 4 h for 48 h, then 1 mg every 4 h. Pre-emptive TIPS within 72 h, ideally 24 h, is for Child-Pugh C 10–13, Child-Pugh B 8–9 with active bleeding at endoscopy, or HVPG above 20 (Baveno VII); ACLF, HE or jaundice at admission do not exclude it. In García-Pagán 2010 (63 patients), it kept 97% vs 50% free of failure or rebleeding at 1 year and raised 1-year survival from 61% to 86%.

TIPS may be futile at Child-Pugh 14–15, or MELD above 30 with lactate above 12 mmol/L, unless transplant is near (Baveno VII). Six-week mortality was 16% in Reverter 2014. Secondary prophylaxis is a beta-blocker plus band ligation.

TIPS and balloon tamponade

TIPS joins a hepatic vein to a portal branch with a covered 8–10 mm stent, aiming for a portal pressure gradient below 12 mm Hg (Baveno VII); it loads the right heart and diverts ammonia past the liver. Heart failure, severe pulmonary hypertension, uncontrolled sepsis and unrelieved biliary obstruction contraindicate it (AASLD 2010). MELD was first built to predict death after elective TIPS (Malinchoc 2000).

Balloon tamponade compresses inflow at the gastroesophageal junction; rebleeding on deflation is common, so it only bridges to TIPS. Baveno VII rates esophageal stents as equally effective and safer (Escorsell 2016, 28 patients: bleeding control 85% vs 47%, serious adverse events 15% vs 47%).

TubeLumensGastric balloon
Sengstaken-BlakemoreGastric and esophageal balloons, gastric suction250–300 mL air
MinnesotaAdds suction above the esophageal balloon450–500 mL air
Linton-NachlasOne large gastric balloon, for gastric varicesAbout 600 mL
  1. Intubate; test both balloons, recording the pressure at each 100 mL of air
  2. Insert by mouth to at least 50 cm; partly inflate the gastric balloon and confirm it below the diaphragm on x-ray
  3. Finish inflating in steps; a pressure 15 mm Hg above the pre-insertion value means esophageal placement
  4. Pull up to the gastroesophageal junction and apply light traction (about 0.5–1 kg)
  5. Esophageal balloon only for continued bleeding: 30–45 mm Hg by manometer
  6. Mark the tube at the lips and check hourly; suction above the esophageal balloon
  7. Scissors at the bedside: for airway obstruction, cut all lumens and pull the tube
  8. Remove within 24 h (Baveno VI)

Cirrhosis complications: ascites, SBP, HRS and encephalopathy

Tap new ascites and every admitted patient with ascites (AASLD 2021). A serum–ascites albumin gradient of 1.1 g/dL or more means portal hypertension; ascitic protein below 1.5 g/dL raises SBP risk. Give 2 g sodium a day with spironolactone 100 mg and furosemide 40 mg (up to 400 and 160 mg), and albumin 6–8 g per liter for paracentesis over 5 L. Routine plasma or platelets before paracentesis are not needed.

SBP is an ascitic neutrophil count of 250/mm³ or more; inoculate blood culture bottles at the bedside. Two of protein above 1 g/dL, glucose below 50 mg/dL and LDH above the serum normal, or polymicrobial growth, suggest surgical peritonitis. Give cefotaxime or ceftriaxone plus albumin 1.5 g/kg at diagnosis and 1 g/kg on day 3 (Sort 1999: renal impairment 10% vs 33%, in-hospital death 10% vs 29%).

HRS-AKI (ICA 2015 criteria, used by AASLD 2021) needs cirrhosis with ascites; creatinine up 0.3 mg/dL in 48 h or 50% in 7 days; no response to 2 days of diuretic withdrawal and albumin 1 g/kg/day; no shock or nephrotoxins; and no proteinuria over 500 mg/day, hematuria or abnormal ultrasound. ADQI–ICA 2024 adds urine output and drops the mandatory 48-h albumin challenge.

Terlipressin, a V₁ agonist, reversed HRS in 32% vs 17% in CONFIRM (2021, 300 patients), but 11% vs 2% died of respiratory disorders. Label dose: 0.85 mg IV every 6 h, raised to 1.7 mg on day 4 if creatinine has fallen less than 30%, for up to 14 days; benefit is unlikely above creatinine 5 mg/dL. Norepinephrine 0.5–3 mg/h is the alternative (ADQI–ICA 2024); transplant is definitive.

Covert HE: minimal and grade 1; overt HE: grades 2–4 (AASLD–EASL 2014).
West HavenFindings
MinimalAbnormal psychometric tests only
Grade 1Short attention, euphoria or anxiety, sleep reversal
Grade 2Lethargy, disorientation to time, asterixis
Grade 3Somnolent but rousable, gross disorientation
Grade 4Coma

Find the trigger: infection, bleeding, dehydration, hypokalemia, constipation, sedatives or TIPS. A high ammonia adds nothing diagnostic in cirrhosis, but a normal one should prompt a search for another cause (AASLD–EASL 2014). Give lactulose 25 mL every 1–2 h until two soft stools, then 2–3 a day; rifaximin 550 mg twice daily cut breakthrough HE from 45.9% to 22.1% (Bass 2010), and 4 L of PEG 3350 beat lactulose at 24 h (HELP 2014: 91% vs 52%). Keep protein at 1.2–1.5 g/kg/day.

Acute-on-chronic liver failure grade 3 (three or more organ failures) carried 77% 28-day mortality in CANONIC (Moreau 2013). Raising albumin to 3 g/dL in inpatients did not reduce infection, kidney dysfunction or death (ATTIRE 2021: 29.7% vs 30.2%) and caused more serious adverse events.

Acute liver failure: causes, prognosis and transplant

Acute liver failure is an INR of 1.5 or more with any encephalopathy, without cirrhosis, in an illness under 26 weeks (AASLD 2011). Hyperacute ALF (jaundice to HE within 1 week: acetaminophen, viral, ischemic) has the most cerebral edema but the best spontaneous recovery; subacute ALF (4–12 weeks: drugs, indeterminate) is the reverse (O'Grady).

Wilson ratios: Korman 2008. In non-acetaminophen ALF with HE grade 1–2, NAC raised transplant-free survival (52% vs 30%, Lee 2009).
CauseCluesTreatment
Acetaminophen (about half in the US)AST in the thousands, low bilirubinIV NAC
Drug, herbal or indeterminateSubacute, deep jaundiceStop drug; NAC if HE grade 1–2
Hepatitis B; herpes simplexHBsAg, anti-HBc IgM; fever, HSV PCRTenofovir or entecavir; acyclovir
Wilson diseaseHemolysis, ALP:bilirubin <4, AST:ALT >2.2Transplant
AFLP or HELLPThird trimesterDelivery

King's College criteria (O'Grady 1989), acetaminophen: arterial pH below 7.30 after fluids, or INR above 6.5 plus creatinine above 3.4 mg/dL plus grade 3–4 HE; Bernal 2002 added lactate above 3.5 mmol/L at 4 h or 3.0 at 12 h. Other causes: INR above 6.5, or three of age under 10 or over 40, drug or indeterminate cause, jaundice over 7 days before HE, INR above 3.5 and bilirubin above 17.5 mg/dL. They are specific but insensitive (sensitivity 68%, specificity 82% in non-acetaminophen ALF, McPhail 2010).

Astrocytes turn ammonia into glutamine and swell; intracranial hypertension developed in 55% of patients with arterial ammonia above 200 µmol/L (Bernal 2007). Intubate at grade 3; keep HOB 30°, PaCO₂ 34–42 mm Hg and normothermia, check glucose every 1–2 h, and start CRRT early. Murphy 2004 held sodium at 145–155 mmol/L with hypertonic saline; EASL 2017 keeps 140–145, treats surges with hypertonic saline or mannitol, and adds brief hyperventilation to PaCO₂ 25–30 if they resist; lactulose has no role. ICP monitors did not improve 21-day survival in ALFSG data (33% vs 38%; bleeding in 7%; Karvellas 2014).

The INR overstates bleeding risk: thromboelastography was normal in 63% despite a mean INR of 3.4 (Stravitz 2012). EASL 2017 advises against prophylactic plasma or platelets, which risk thrombosis and lung injury and erase the INR trend used for transplant decisions; correct only for bleeding or procedures.

Contact a transplant center once INR exceeds 1.5 with any HE (EASL 2017). For transfer with evolving HE, intubate and sedate first, keep vasopressors drawn up and carry mannitol in case the pupils dilate en route. UNOS Status 1A requires HE within 56 days of first symptoms, no prior liver disease, ICU care, and ventilation, dialysis or INR above 2.0 (OPTN Policy 9.1.A). High-volume plasma exchange improved hospital survival (58.7% vs 47.8%, Larsen 2016). Uncontrolled sepsis, fixed dilated pupils and severe cardiopulmonary disease weigh against transplant.

Alcohol-associated hepatitis

NIAAA 2016: jaundice within 8 weeks of heavy drinking, bilirubin above 3 mg/dL, AST above 50 IU/L with AST:ALT above 1.5, both below 400. Screen for infection (cultures, chest x-ray, paracentesis) before steroids.

ScoreInputsThreshold
Maddrey DF4.6 × (PT − control PT) + bilirubin≥32: severe
MELDBilirubin, INR, creatinine>20: severe (ACG 2024)
Lille (day 7)Includes bilirubin change on steroids≥0.45: nonresponse, stop steroids

Prednisolone is 40 mg daily for 28 days. STOPAH (2015, 1,103 patients) found 28-day mortality of 14% vs 17% with placebo (OR 0.72, p=0.06), no benefit at 90 days, more serious infections (13% vs 7%) and nothing from pentoxifylline. Steroids helped at 30 days only at MELD 21–51, most at 25–39 (Arab 2021, 3,380 patients). IV NAC added to prednisolone lowered 1-month (8% vs 24%) but not 6-month mortality (Nguyen-Khac 2011). Early transplant for selected nonresponders gave 6-month survival of 77% vs 23% (Mathurin 2011); a Lille score of 0.45 or more had predicted 6-month survival of 25% vs 85% (Louvet 2007).

Feed 35–40 kcal/kg and 1.2–1.5 g/kg of protein a day (AASLD–EASL 2014 targets), give thiamine before glucose, and treat alcohol use disorder: abstinence decides long-term survival.

Acute pancreatitis: severity, fluids and nutrition

Trypsin activated inside acinar cells causes autodigestion, SIRS and capillary leak; a rising hematocrit and BUN mark third-spacing. The revised Atlanta classification (Banks 2013) grades severity by organ failure.

Organ failure: modified Marshall ≥2 (PaO₂/FiO₂ ≤300, creatinine ≥1.9 mg/dL, or SBP <90 despite fluid).
SeverityDefinition
MildNo organ failure, no local or systemic complications
Moderately severeOrgan failure under 48 h or local complications
SevereOrgan failure persisting beyond 48 h

BISAP gives a point each in the first 24 h for BUN above 25 mg/dL, impaired mentation, SIRS, age above 60 and pleural effusion; mortality runs from under 1% to over 20% (Wu 2008). ACG 2024 warns that no score predicts severity reliably and advises against CT on admission just to stage it.

WATERFALL (2022, 249 patients) compared aggressive lactated Ringer's (20 mL/kg, then 3 mL/kg/h) with moderate (10 mL/kg only if hypovolemic, then 1.5 mL/kg/h) and stopped early: fluid overload 20.5% vs 6.3%, with no fewer moderately severe or severe cases (22.1% vs 17.3%). ACG 2024 suggests moderate, goal-directed Ringer's, reassessed within 6 h, aiming for a falling BUN.

ACG 2024 suggests low-fat solid food within 24–48 h as tolerated, enteral over parenteral nutrition when needed, and no prophylactic antibiotics. In PYTHON (2014, 208 patients), tube feeding within 24 h was no better than oral diet at 72 h (infection or death 30% vs 27%). Urgent ERCP is for cholangitis only (APEC 2020: 38% vs 44%), and same-admission cholecystectomy cut gallstone readmissions (4.7% vs 16.9%, PONCHO 2015). Treat pain with opioids and check ionized calcium and glucose.

Necrotizing pancreatitis and abdominal compartment syndrome

Revised Atlanta local complications.
TypeUnder 4 weeksAfter 4 weeks (walled off)
Interstitial edematousAcute peripancreatic fluid collectionPseudocyst
NecrotizingAcute necrotic collectionWalled-off necrosis

Infection of necrosis appears after the first week with fever, rising WBC, new organ failure or gas on CT. Give antibiotics that penetrate necrosis (carbapenem, quinolone or metronidazole) and delay intervention, preferably 4 weeks, until the collection is walled off (ACG 2024). Endoscopic transgastric drainage, often with lumen-apposing metal stents, avoids external pancreatic fistulas.

In PANTER, 35% of step-up patients needed only drainage; in POINTER, 39% of the postponed group needed only antibiotics.
TrialComparisonResult
PANTER 2010, 88 patientsStep-up vs open necrosectomyMajor complications or death 40% vs 69%
TENSION 2018, 98 patientsEndoscopic vs surgical step-up43% vs 45%; fewer fistulas
POINTER 2021, 104 patientsDrainage at diagnosis vs postponedNo benefit; more procedures

WSACS 2013: intra-abdominal hypertension is sustained IAP of 12 mm Hg or more (grade I 12–15, II 16–20, III 21–25, IV over 25); abdominal compartment syndrome is IAP above 20 with new organ dysfunction. Abdominal perfusion pressure is MAP minus IAP, and the renal filtration gradient is roughly MAP minus twice the IAP, so oliguria comes early.

  1. Patient supine and flat; head elevation raises the reading
  2. Zero the transducer at the midaxillary line at the iliac crest
  3. Instill no more than 25 mL of sterile saline into the bladder
  4. Wait 30–60 s for detrusor relaxation; read at end-expiration, in mm Hg

Then decompress the gut, drain ascites or collections, deepen analgesia and sedation, avoid a positive fluid balance, and decompress surgically if organ failure persists (WSACS 2013).

Exam pearls

Practice free in your browser3,800+ exam-style questions with rationales. No account, no ads. Also free on the App Store and Google Play.

Related one-pagers

Calculators for this topic

Sources

  1. Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol. 2021;116(5):899-917. Link
  2. de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-974. Link
  3. Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by AASLD. Hepatology. 2021;74(2):1014-1048. Link
  4. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by AASLD and EASL. Hepatology. 2014;60(2):715-735. Link
  5. European Association for the Study of the Liver. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047-1081. Link
  6. de-Madaria E, Buxbaum JL, Maisonneuve P, et al. Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis (WATERFALL). N Engl J Med. 2022;387(11):989-1000. Link
  7. Tenner S, Vege SS, Sheth SG, et al. American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. Am J Gastroenterol. 2024;119(3):419-437. Link